Gillian Moore

622 total citations
16 papers, 414 citations indexed

About

Gillian Moore is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Organic Chemistry. According to data from OpenAlex, Gillian Moore has authored 16 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 4 papers in Organic Chemistry. Recurrent topics in Gillian Moore's work include Cancer Mechanisms and Therapy (6 papers), Quinazolinone synthesis and applications (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Gillian Moore is often cited by papers focused on Cancer Mechanisms and Therapy (6 papers), Quinazolinone synthesis and applications (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Gillian Moore collaborates with scholars based in Ireland, Australia and United Kingdom. Gillian Moore's co-authors include Tracy Robson, Stephanie Annett, Graham P. Pidgeon, Lana McClements, Sinéad Cuffe, Susan Heavey, Stephen P. Finn, Kathy Gately, Frank Moriarty and Nathalie Simon and has published in prestigious journals such as Nature, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Gillian Moore

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillian Moore Ireland	9	178	130	90	68	56	16	414
Anna Hester Germany	12	174 1.0×	115 0.9×	97 1.1×	129 1.9×	29 0.5×	42	437
Xuexian Yan Singapore	7	152 0.9×	117 0.9×	55 0.6×	74 1.1×	96 1.7×	16	414
Lele Song China	12	268 1.5×	163 1.3×	144 1.6×	47 0.7×	48 0.9×	30	499
Emma T. Lundsmith United States	7	320 1.8×	198 1.5×	160 1.8×	72 1.1×	49 0.9×	7	610
Keshab R. Parajuli United States	11	243 1.4×	153 1.2×	98 1.1×	76 1.1×	24 0.4×	22	503
Samina Dongol China	14	266 1.5×	98 0.8×	202 2.2×	37 0.5×	52 0.9×	17	463
Virginie Quidville France	8	228 1.3×	88 0.7×	129 1.4×	42 0.6×	20 0.4×	10	398
Dianren Xia United States	10	314 1.8×	114 0.9×	120 1.3×	67 1.0×	45 0.8×	17	487
Bastian Czogalla Germany	15	237 1.3×	176 1.4×	103 1.1×	141 2.1×	74 1.3×	64	620
Keara L. Redmond United Kingdom	9	310 1.7×	205 1.6×	60 0.7×	96 1.4×	63 1.1×	11	510

Countries citing papers authored by Gillian Moore

Since Specialization

Citations

This map shows the geographic impact of Gillian Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Moore more than expected).

Fields of papers citing papers by Gillian Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Moore. The network helps show where Gillian Moore may publish in the future.

Co-authorship network of co-authors of Gillian Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Moore. A scholar is included among the top collaborators of Gillian Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Moore. Gillian Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Moore, Gillian, Lauren Brady, Siobhan Nicholson, et al.. (2021). Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. Cancers. 13(9). 2139–2139. 8 indexed citations

Annett, Stephanie, Shaun Spence, Carolina D. Garciarena, et al.. (2021). The Immunophilin Protein FKBPL and its Peptide Derivatives are Novel Regulators of Vascular Integrity and Inflammation via Nf-κB Signaling. SSRN Electronic Journal. 1 indexed citations

Moriarty, Frank, et al.. (2021). Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis. Cancers. 13(7). 1649–1649. 23 indexed citations

Annett, Stephanie, Gillian Moore, & Tracy Robson. (2020). FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention. Pharmacology & Therapeutics. 215. 107623–107623. 66 indexed citations

Moore, Gillian, Stephanie Annett, Lana McClements, & Tracy Robson. (2020). Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells. 9(6). 1503–1503. 94 indexed citations

Annett, Stephanie, Gillian Moore, & Tracy Robson. (2020). Obesity and Cancer Metastasis: Molecular and Translational Perspectives. Cancers. 12(12). 3798–3798. 61 indexed citations

Simon, Nathalie, Susan Heavey, Sinéad Cuffe, et al.. (2019). Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer. Pharmacology & Therapeutics. 207. 107454–107454. 28 indexed citations

Madsen, Anne Tranberg, Gillian Moore, Nathalie Simon, et al.. (2019). P2.03-19 Co-Targeting PIM Kinase to Overcome MET Amplified Resistance to EGFR TKIs in NSCLC. Journal of Thoracic Oncology. 14(10). S690–S690. 1 indexed citations

Heavey, Susan, Paul Dowling, Gillian Moore, et al.. (2018). Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines. Scientific Reports. 8(1). 1652–1652. 12 indexed citations

10.

Gately, Kathy, Susan Heavey, Sinéad Cuffe, et al.. (2018). PO-505 Targeting PIM kinase to overcome resistance to PI3K-mTOR inhibition in NSCLC. ESMO Open. 3. A219–A220. 1 indexed citations

11.

Moore, Gillian, et al.. (2018). pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus. International Journal of Molecular Sciences. 19(6). 1720–1720. 10 indexed citations

12.

Moore, Gillian, Susan Heavey, Kenneth J. O’Byrne, et al.. (2018). Activated cMyc/PIM kinase promotes resistance to PI3K/mTOR inhibition in NSCLC. Lung Cancer. 115. S2–S2. 1 indexed citations

13.

Moore, Gillian, Susan Heavey, Lauren Brady, et al.. (2017). P1.02-065 Elucidating the Role of PIM Kinase and Its Therapeutic Potential in NSCLC. Journal of Thoracic Oncology. 12(1). S527–S528. 1 indexed citations

14.

Moore, Gillian & Graham P. Pidgeon. (2017). Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. International Journal of Molecular Sciences. 18(2). 236–236. 88 indexed citations

15.

Conroy, Melissa J., Karen Galvin, Suzanne L. Doyle, et al.. (2016). Parallel Profiles of Inflammatory and Effector Memory T Cells in Visceral Fat and Liver of Obesity-Associated Cancer Patients. Inflammation. 39(5). 1729–1736. 18 indexed citations

16.

Moore, Gillian. (1973). Game of Chance. Nature. 246(5433). 436–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact